Roche Mulls Sub-Licensing Bird Flu Drug
Roche Pharmaceuticals is considering sub-licensing its avian flu treatment Tamiflu amid calls for patent overrides from politicians such as New York Senator Charles E. Schumer....To view the full article, register now.
Already a subscriber? Click here to view full article